[
  {
    "variant_string_id": "EGFR L858R",
    "functional_evidence_aim": "Pathogenic",
    "assessment_steps": [
      {
        "step_name": "Step 1: Define the disease mechanism",
        "extracted_paper_info": "The paper describes EGFR mutations, specifically L858R, as activating mutations that drive uncontrolled cell proliferation in lung cancer. The study aims to understand the functional consequences of these mutations.",
        "judgment": "Yes",
        "reasoning": "The paper clearly establishes EGFR mutations, including L858R, as key drivers of cancer pathogenesis through uncontrolled cell growth.",
        "next_step_or_outcome": "Proceed to Step 3"
      },
      {
        "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
        "extracted_paper_info": "The study utilizes a protein interaction assay to examine the effects of the L858R mutation on EGFR phosphorylation and downstream signaling. This assay allows for assessment of the mechanism by which the mutation drives oncogenic signaling.",
        "judgment": "Yes",
        "reasoning": "Protein interaction assays are commonly used to evaluate the effects of mutations on protein phosphorylation and signaling pathways, which is relevant to the established disease mechanism.",
        "next_step_or_outcome": "Proceed to Step 3"
      },
      {
        "step_name": "Step 3: Evaluate validity of specific instances of assays.",
        "extracted_paper_info": "The assay was performed with both wild-type and mutant EGFR proteins. Replicates were conducted across multiple independent experiments (n=3).  The experimental design included known loss-of-function mutations as controls. ",
        "judgment": "Yes",
        "reasoning": "The assay incorporated both wild-type and mutant protein controls, along with replicates across multiple experiments. This provides sufficient controls and replicates.",
        "next_step_or_outcome": "Proceed to Step 3c"
      },
      {
        "step_name": "Step 3c: Variant Controls",
        "extracted_paper_info": "The study included known pathogenic EGFR mutations as controls. ",
        "judgment": "Yes",
        "reasoning": "Known pathogenic variants served as controls. ",
        "next_step_or_outcome": "Proceed to Step 4"
      },
      {
        "step_name": "Step 4: Apply evidence to individual variant interpretation.",
        "extracted_paper_info": "Statistical analyses were used to quantify the differences in phosphorylation levels between wild-type and mutant EGFR. OddsPath calculations were performed, reporting a calculated OddsPath of 25 for L858R.",
        "judgment": "Yes",
        "reasoning": "OddsPath was calculated to estimate the pathogenicity likelihood for the variant.",
        "next_step_or_outcome": "Final Strength Assignment"
      }
    ],
    "final_evidence_strength": {
      "type": "Pathogenic",
      "strength": "PS3_very_strong"
    },
    "overall_conclusion": "The study used a validated protein interaction assay, incorporated appropriate controls including wild-type and pathogenic variants, included replicates in multiple independent experiments (n=3), and performed statistical analyses including OddsPath calculations. Given the OddsPath of 25 for L858R, this variant is classified as PS3_very_strong, indicating strong evidence of pathogenicity."
  }
]